China SXT Pharmaceuticals Ownership 2024 | Who Owns China SXT Pharmaceuticals Now?


OverviewRevenueFinancialsChart

Institutional Ownership

3.37%

Insider Ownership

25.06%

Retail Ownership

71.57%

Institutional Holders

4.00

China SXT Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC4.11%0.00%105,03959,519130.75%28,000Mar 31, 2023
VIRTU FINANCIAL LLC1.54%0.00%39,427-49,730-55.78%11,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC1.35%-34,50034,500100.00%10,000Mar 31, 2023
CITADEL ADVISORS LLC0.95%-24,41024,410100.00%7,018,000Mar 31, 2023
UBS GROUP AG0.70%-17,9457,32969.04%5,096,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC0.61%0.00%15,506-29,144-65.27%4,398,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----67,648-100.00%-Mar 31, 2023

China SXT Pharmaceuticals's largest institutional shareholder is ACADIAN ASSET MANAGEMENT LLC, holding 4.11% of the company's total share outstanding, currently valued at $28.00K. The top 10 institutional shareholders own together 9.26% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VIRTU FINANCIAL LLC1.54%0.00%39,427-49,730-55.78%11,000Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC4.11%0.00%105,03959,519130.75%28,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC0.61%0.00%15,506-29,144-65.27%4,398,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC1.35%-34,50034,500100.00%10,000Mar 31, 2023
UBS GROUP AG0.70%-17,9457,32969.04%5,096,000Mar 31, 2023
CITADEL ADVISORS LLC0.95%-24,41024,410100.00%7,018,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----67,648-100.00%-Mar 31, 2023

The largest China SXT Pharmaceuticals shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 39.43K shares of China SXT Pharmaceuticals (SXTC), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC4.11%0.00%105,03959,519130.75%28,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC1.35%-34,50034,500100.00%10,000Mar 31, 2023
CITADEL ADVISORS LLC0.95%-24,41024,410100.00%7,018,000Mar 31, 2023
UBS GROUP AG0.70%-17,9457,32969.04%5,096,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC0.61%0.00%15,506-29,144-65.27%4,398,000Mar 31, 2023
VIRTU FINANCIAL LLC1.54%0.00%39,427-49,730-55.78%11,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----67,648-100.00%-Mar 31, 2023

As of Mar 31 2023, China SXT Pharmaceuticals's largest institutional buyer is ACADIAN ASSET MANAGEMENT LLC. The company purchased 59.52K stocks of SXTC, valued at $28.00K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----67,648-100.00%-Mar 31, 2023
VIRTU FINANCIAL LLC1.54%0.00%39,427-49,730-55.78%11,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC0.61%0.00%15,506-29,144-65.27%4,398,000Mar 31, 2023
UBS GROUP AG0.70%-17,9457,32969.04%5,096,000Mar 31, 2023
CITADEL ADVISORS LLC0.95%-24,41024,410100.00%7,018,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC1.35%-34,50034,500100.00%10,000Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC4.11%0.00%105,03959,519130.75%28,000Mar 31, 2023

As of Mar 31 2023, China SXT Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -67.65K shares of SXTC, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC1.35%-34,50034,500100.00%10,000Mar 31, 2023
CITADEL ADVISORS LLC0.95%-24,41024,410100.00%7,018,000Mar 31, 2023

China SXT Pharmaceuticals's largest new institutional shareholder by number of shares is RENAISSANCE TECHNOLOGIES LLC, purchased 34.50K shares, valued at $10.00K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----67,648-100.00%-Mar 31, 2023

China SXT Pharmaceuticals's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -67.65K shares, valued at -, as of undefined.

China SXT Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 204-55.56%
30 Sep, 20912.50%
30 Jun, 20833.33%
31 Mar, 20650.00%
31 Dec, 19433.33%
30 Sep, 193-25.00%
30 Jun, 19433.33%
31 Mar, 193-

As of 31 Dec 20, 4 institutions are holding China SXT Pharmaceuticals's shares, representing a decrease of -55.56% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 20833,899-73.46%
30 Sep, 203,142,433-28.52%
30 Jun, 204,396,29555.53%
31 Mar, 202,826,60728.44%
31 Dec, 192,200,6726.75%
30 Sep, 192,061,5550.72%
30 Jun, 192,046,8404690.73%
31 Mar, 1942,725-

China SXT Pharmaceuticals (SXTC) has 833.90K shares outstanding as of 31 Dec 20, down -73.46% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 203.37%2.09%
30 Sep, 2012.71%4.02%
30 Jun, 2017.78%13.61%
31 Mar, 2011.43%14.43%
31 Dec, 198.90%12.80%
30 Sep, 198.34%8.42%
30 Jun, 199.95%23065.62%
31 Mar, 190.21%-

As of 31 Dec 20, China SXT Pharmaceuticals is held by 3.37% institutional shareholders, representing a 2.09% growth compared to 30 Sep 20.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 203-50.00%
30 Sep, 206-
30 Jun, 206-
31 Mar, 206100.00%
31 Dec, 193-
30 Sep, 193-
30 Jun, 193-
31 Mar, 193-

3 institutional shareholders have increased their position in SXTC stock as of 31 Dec 20 compared to 6 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 201-50.00%
30 Sep, 202100.00%
30 Jun, 201-
31 Mar, 20--100.00%
31 Dec, 191-
30 Sep, 19--100.00%
30 Jun, 191-
31 Mar, 19--

1 institutional shareholders have reduced their position in SXTC stock as of 31 Dec 20 compared to 2 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 204-55.56%833,899-73.46%3.37%2.09%3-50.00%1-50.00%
30 Sep, 20912.50%3,142,433-28.52%12.71%4.02%6-2100.00%
30 Jun, 20833.33%4,396,29555.53%17.78%13.61%6-1-
31 Mar, 20650.00%2,826,60728.44%11.43%14.43%6100.00%--100.00%
31 Dec, 19433.33%2,200,6726.75%8.90%12.80%3-1-
30 Sep, 193-25.00%2,061,5550.72%8.34%8.42%3---100.00%
30 Jun, 19433.33%2,046,8404690.73%9.95%23065.62%3-1-
31 Mar, 193-42,725-0.21%-3---

China SXT Pharmaceuticals Peer Ownership


TickerCompany
PTPIPetros Pharmaceuticals, Inc.
ALIMAlimera Sciences, Inc.
AKANAkanda Corp.
RGCRegencell Bioscience Holdings Limited
SHPHShuttle Pharmaceuticals Holdings, Inc.
ACORAcorda Therapeutics, Inc.
SBFMSunshine Biopharma, Inc.
BFRIBiofrontera Inc.
HUGEFSD Pharma Inc.
PROCProcaps Group S.A.
JUPWSafety Shot Inc
GHSIGuardion Health Sciences, Inc.
PRFXPainReform Ltd.
QLIQilian International Holding Group Limited
LSDILucy Scientific Discovery Inc.

SXTC Ownership FAQ


China SXT Pharmaceuticals is owned by institutional shareholders (3.37%), insiders (25.06%), and public (71.57%). The largest institutional shareholder of China SXT Pharmaceuticals is ACADIAN ASSET MANAGEMENT LLC (4.11% of total shares) and the top mutual fund owner is (0% of total shares).

China SXT Pharmaceuticals's major institutional shareholders are ACADIAN ASSET MANAGEMENT LLC, VIRTU FINANCIAL LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, and UBS GROUP AG. The top five shareholders own together 8.65% of the company's share outstanding.

As of Dec 2020, there are 4 institutional shareholders of China SXT Pharmaceuticals.

ACADIAN ASSET MANAGEMENT LLC owns 105.04K shares of China SXT Pharmaceuticals, representing 4.11% of the company's total shares outstanding, valued at $28K (as of Mar 2023).

As of Mar 2023, VIRTU FINANCIAL LLC holds 39.43K shares of China SXT Pharmaceuticals (SXTC), compromising 1.54% of the company, valued at $11K.

RENAISSANCE TECHNOLOGIES LLC is the third largest holder of China SXT Pharmaceuticals. The company owns 34.5K of the company's shares outstanding (worth $10K).